Search Results for: formulation development amorphous dispersion formu
Articles
SPECIAL REPORT - Outsourcing Formulation Development and Manufacturing: An Early Approach Saves Time and Money March 31, 2013
In this Special Report, Contributor Cindy H. Dubin asks many of the leading companies in this sector what challenges pharma currently faces in formulation and manufacturing and how they, as third-party providers, are helping to alleviate those burdens.
FORMULATION DEVELOPMENT - Bioavailability Enhancement Strategies & Opportunities March 13, 2013
Frost & Sullivan Analyst Ruplekha Choudhurie reviews some BA approaches that are being developed by a number of companies that can mitigate the biological, physical, and chemical barriers for effective delivery of poorly soluble and permeable drugs.
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations February 5, 2012
Foster Delivery Science, a business unit for Foster Corporation, recently announced it has added comprehensive in-house laboratory services to expedite...SPECIAL FEATURE - Excipients: Strategic Enablers of Innovation October 6, 2026
Ahead of CPHI, Cindy H. Dubin learns from leading excipient suppliers how multi-functional and organic excipients are impacting novel formulations and how AI is becoming a valuable tool in formulation development.
SPECIAL REPORT - Excited About Excipients? October 6, 2026
Kurt R. Sedo and Cindy H. Dubin take a deep dive into the excipient market, highlighting how new excipients enable advanced drug products and how AI and computation tools are helping match excipients to APIs.
FDA Grants Advanced Manufacturing Technology Designation to AustinPx’s KinetiSol Platform September 28, 2026
AustinPx has received Advanced Manufacturing Technology (AMT) designation from the U.S. Food and Drug Administration (FDA) for its KinetiSol™ Technology,...AustinPx Expands KinetiSol Technology Commercial Access through Thermo Fisher Scientific Collaboration July 7, 2026
GEORGETOWN, Texas -- AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule...Codis To Acquire Catalent's Nottingham, UK Facility to Create Europe's Leading End-to-End Spray Dry Capability July 6, 2026
HAVERHILL, England, Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and...SPECIAL FEATURE - Bioavailability & Solubility: Experimental Techniques Combined With Computational Decision-Making Rapidly ID the Most Viable Enhancement Pathway April 17, 2026
Contributor Cindy H. Dubin highlights other ways formulators are relying on automation, such as Artificial Intelligence and Machine Learning, and how these tools are being combined with experimental confirmation to identify the most promising development strategies.
ORAL SUSPENSIONS - A New Standard in Oral Suspensions: Leveraging Novel Excipients for FDA Approval December 12, 2025
Mary Schuster introduces a new approach to perfecting oral suspension formulations, which is centered on the strategic use of a “novel” synthetic functional excipient, magnesium aluminometasilicate (MAS).
Hovione Completes Initial $100M Investment Cycle to Expand US Operations at New Jersey Manufacturing Campus October 20, 2025
Hovione, a fully-integrated global CDMO, today announced the completion of an initial multi-million-dollar investment cycle to expand its manufacturing campus...SPECIAL FEATURE - Excipients: Innovation in a Shifting Pharma Landscape October 7, 2025
Cindy H. Dubin speaks with several companies and highlights this innovation and reveals how excipient suppliers are doing their part to ensure a reliable, resilient, and compliance-driven supply chain.
EXCIPIENT TECHNOLOGY - Driving Oral Drug Delivery Innovation With Safe, Reliable Lipid Excipients October 7, 2025
Nick DiFranco, MEM, says amidst the uncertainty of novel ingredients and formulation techniques, lipid excipients provide a safe, proven platform for enhancing in vivo formulation performance, enabling innovation without sacrificing scalability or regulatory confidence.
Aenova expands its advanced technology portfolio with cutting-edge hot melt extrusion platform July 9, 2025
Starnberg, Germany, Aenova, a leading global contract development and manufacturing organization (CDMO), relies on various innovative technologies to improve the...SPECIAL FEATURE - Bioavailability & Solubility: The Promise of Novel Ingredients April 4, 2025
Contributor Cindy H. Dubin, speaks with several innovating companies to discuss the use of novel excipients as well as other methods and technologies for tackling bioavailability and solubility once and for all.
Catalent Boston Adds to Oral Spray Drying Capacity & Capabilities to Support Late-Stage Clinical Trials & Commercialization October 28, 2024
Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies, and flexible manufacturing, has completed a series of...Hovione & Zerion Pharma Create Joint Venture to Further Expand Use of Dispersome Technology October 3, 2024
Hovione Farmaciência, S.A. and Zerion Pharma A/S recently announced they have expanded their partnership to accelerate the development of the...EXECUTIVE INTERVIEW - Lonza: Navigating Today’s Challenges in Drug Solubility & Bioavailability June 3, 2024
Adi Kaushal, Director and Technology Head, Bioavailability Enhancement at Lonza, discusses solubility and bioavailability challenges and Lonza’s approach.
Data From First Human Study Demonstrate Excellent Performance of Zerion Pharma’s Dispersome Technology May 13, 2024
Zerion Pharma A/S recently announced positive results from the first human clinical study of a Dispersome formulation of the drug...Elizabeth Hickman to Succeed Tim Scott as AustinPx CEO March 5, 2024
AustinPx, developers of the next generation amorphous dispersion platform, KinetiSol Technology, and a contract development and manufacturing organization (CDMO), recently announced Elizabeth Hickman, Chief Business Officer, will succeed….
Case study: Modeling polymor interactions to improve amorphous dispersion design
In this case study, OSDPredict™ narrowed formulation options early, focusing development on the most viable strategies which reduced experimental burden and conserved valuable materials.
